Evidence map›Paper›PMID 36555484›Full record

ArticleInternational journal of molecular sciences2022

Conserved Double Translation Initiation Site for Δ160p53 Protein Hints at Isoform's Key Role in Mammalian Physiology.

Maria José López-Iniesta, Shrutee N Parkar, Ana Catarina Ramalho, Rafaela Lacerda, Inês F Costa, Jingyuan Zhao, Luísa Romão, Marco M Candeias

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Maria José López-IniestaMaRCU-Molecular and RNA Cancer Unit, Kyoto 606-8501, Japan.
Shrutee N ParkarMaRCU-Molecular and RNA Cancer Unit, Kyoto 606-8501, Japan.
Ana Catarina RamalhoMaRCU-Molecular and RNA Cancer Unit, Kyoto 606-8501, Japan.ORCID 0000-0003-0296-8632
Rafaela LacerdaMaRCU-Molecular and RNA Cancer Unit, Kyoto 606-8501, Japan.ORCID 0000-0002-5582-9823
Inês F CostaMaRCU-Molecular and RNA Cancer Unit, Kyoto 606-8501, Japan.
Jingyuan ZhaoMaRCU-Molecular and RNA Cancer Unit, Kyoto 606-8501, Japan.
Luísa RomãoDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0002-5061-5287
Marco M CandeiasMaRCU-Molecular and RNA Cancer Unit, Kyoto 606-8501, Japan.ORCID 0000-0002-5731-0179
University of Lisbon · PTKyoto University · JP

Funding

Astellas Research Foundation for Pathophysiology and Metabolism 203180600044Fundação para a Ciência e Tecnologia PTDC/BIM-ONC/4890/2014Fundação para a Ciência e Tecnologia PTDC/MED-ONC/32048/2017Japan Society for the Promotion of Science 18K07229Takeda (Japan) 2017 Medical Research Fellowship (Oncology, Basic)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsTumor Suppressor Protein p53CodonCodon, InitiatorHumansMutationProtein BiosynthesisProtein IsoformsCodonCodon, InitiatorProtein IsoformsTumor Suppressor Protein p53cancerp53p53 isoformp53 mRNAtranslationΔ160p53

Identifiers

PMID36555484
PMCPMC9779343
OpenAlexW4311480258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.